ZAGATTI, Barbara
 Distribuzione geografica
Continente #
NA - Nord America 1.860
EU - Europa 579
AS - Asia 338
Totale 2.777
Nazione #
US - Stati Uniti d'America 1.860
CN - Cina 182
PL - Polonia 142
IT - Italia 120
UA - Ucraina 86
TR - Turchia 81
DE - Germania 60
SE - Svezia 58
GB - Regno Unito 52
SG - Singapore 39
FI - Finlandia 23
RO - Romania 19
ID - Indonesia 12
VN - Vietnam 11
FR - Francia 7
BE - Belgio 6
HK - Hong Kong 5
IR - Iran 4
IN - India 3
CZ - Repubblica Ceca 1
GR - Grecia 1
HR - Croazia 1
IE - Irlanda 1
NL - Olanda 1
NO - Norvegia 1
UZ - Uzbekistan 1
Totale 2.777
Città #
Fairfield 290
Houston 195
Woodbridge 193
Chandler 148
Warsaw 142
Ann Arbor 132
Ashburn 126
Seattle 112
Jacksonville 108
Wilmington 101
Cambridge 88
Ferrara 59
Izmir 49
Beijing 46
Nanjing 35
Milan 28
Princeton 25
Shanghai 25
New York 24
Boardman 20
Singapore 19
Los Angeles 18
San Diego 18
Timisoara 17
Nanchang 13
Bremen 11
Falls Church 11
Jakarta 11
Shenyang 10
Changsha 9
Dong Ket 9
Addison 8
Hebei 8
Dearborn 7
London 7
Brussels 6
Jiaxing 6
Augusta 5
Mountain View 5
Orange 5
Tianjin 5
Auburn Hills 4
Guangzhou 4
Hong Kong 4
Ningbo 4
Washington 4
Ardabil 3
Bologna 3
Castelmassa 3
Des Moines 3
Kunming 3
Leawood 3
Norwalk 3
Tappahannock 3
Zhengzhou 3
Changchun 2
Focsani 2
Hangzhou 2
Hanoi 2
Jinan 2
Monmouth Junction 2
Monte San Pietro 2
Redwood City 2
Salò 2
San Giorgio Di Piano 2
San Mateo 2
Brentwood 1
Brno 1
Chicago 1
Costabissara 1
Dublin 1
Edinburgh 1
Hefei 1
Helsinki 1
Hounslow 1
Imola 1
Kilburn 1
McDonough 1
Pasadena 1
Pavullo Nel Frignano 1
Pune 1
Redmond 1
Rome 1
Salt Lake City 1
San Francisco 1
San Jose 1
Santa Clara 1
Taglio Di Po 1
Taizhou 1
Trieste 1
Ulm 1
Verona 1
Zagreb 1
Totale 2.250
Nome #
Absolute quantification of cell-free microRNAs in cancer patients 178
MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab 172
MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer 146
miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model 146
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 139
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression 136
Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma 131
MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin 129
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 124
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 119
microRNAome Expression in Chronic Lymphocytic Leukemia: Comparison with Normal B-cell Subsets and Correlations with Prognostic and Clinical Parameters 115
MiR-145 participates with TP53 in a death promoting regulatory loop and targets estrogen receptor in human breast cancer cells 112
null 109
Clinical Monoclonal B lymphocytosis versus Rai 0 Chronic Lymphocytic Leukemia: a Comparison of Cellular, Cytogenetic, Molecular, and Clinical Features 107
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 106
Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia 106
Characterisation of peripheral blood mononuclear cell microRNA in early onset psoriatic arthritis 100
Investigations on microRNAs in human chronic lymphocytic leukemia and control of cancer-associated molecular pathways 95
null 89
miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eµ-TCL1 mouse model 78
EPIGENETIC CHANGES AT CHROMOSOME REGION 11p15.5 IN HUMAN CANCER 77
null 77
MicroRNA expression profile in peripheral blood cells of psoriatic arthritis 71
KVDMR1, A LOCUS FREQUENTLY HYPOMETHYLATED IN HUMAN CANCER, IS A STRONG ENHANCER-PROMOTER ELEMENT FOR THE EXPRESSION OF LIT1, AN UNTRANSLATED IMPRINTOR GENE AT CHROMOSOME 11p15.5. 62
Altered miRNA expression in T regulatory cells in course of multipla sclerosis 56
How to fish a good micro-marker out from a worthless lake: The case of cell-free miR-181a-5p and breast cancer 27
Altered miRNA expression in T regulatory cells in course of multiple sclerosis 22
miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs 19
Totale 2.848
Categoria #
all - tutte 11.377
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.377


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020491 0 20 15 89 45 66 47 52 53 53 24 27
2020/2021599 44 58 40 50 41 60 26 52 12 98 66 52
2021/2022347 13 30 35 14 23 16 23 26 6 23 41 97
2022/2023311 30 35 5 54 39 48 26 21 37 1 6 9
2023/2024198 15 24 9 3 15 42 11 12 5 13 0 49
2024/202529 17 12 0 0 0 0 0 0 0 0 0 0
Totale 2.848